Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using AI feedback to improve diagnostic reasoning in kidney medicine

Official title: Reasoning Enhancement With Feedback From a Generative AI in Nephrology (REFINe): A Randomized Evaluation of Generative AI Support in Nephrology Diagnosis

Run by University Hospital, Lille · NCT07352475 · Data updated 2026-11-12

This test sees if an advanced AI language model can help medical students, residents, fellows, and physicians make more accurate and confident kidney-related diagnoses using online clinical cases.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Lille
Academic / other
Locations1 site (Lille)
StatusRecruiting
StartedNovember 20, 2025
Main results expectedOctober 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 20, 2026
Trial IDNCT07352475 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults with at least basic medical training (medical students, residents, fellows, or practicing clinicians) who can read English or French and have internet access.

Probably not a fit

People without medical training, those under 18, or anyone unable to complete online procedures or who lacks English/French ability or internet access are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Clinicians are randomized to either receive real-time diagnostic suggestions from a high-reasoning GPT-5-class model or to complete cases without AI support, and each participant completes up to 10 nephrology clinical vignettes presented in English or French. The research team previously benchmarked multiple state-of-the-art models and selected GPT-5 (high-reasoning) based on diagnostic performance, stability, and interpretability. Participants create an account, provide demographic information, consent to data use, and complete vignettes online without backtracking while completion time and responses are recorded. Analysis compares diagnostic accuracy, confidence, and decision-making between the AI-supported and control arms with stratified randomization by professional status.

Why it matters

Potential benefit: If successful, clinicians could arrive at correct nephrology diagnoses more often and with greater confidence, which may translate into faster or more appropriate patient care.

How similar studies have gone: Previous vignette and reader studies using earlier large language models and decision-support tools have sometimes improved diagnostic accuracy but have produced mixed results, so this application is promising but not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18 years or older.

Able to read and answer clinical vignettes in English or French.

Access to a computer or smartphone with an internet connection.

Provides informed consent online.

Participants are expected to have at least basic medical training (e.g., medical students, residents, fellows, or practicing clinicians), although no formal verification is required.

Exclusion Criteria:

Individuals under 18 years of age.

Inability to complete online study procedures.

Prior involvement in the design, development, or evaluation of the AI system used in this study.

Where it's running

  • Lille University Hospital (online study)
    Lille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.